Rystiggo (rozanolixizumab)

pCPA File Number: 23135

Negotiation Status:

Under consideration for negotiation

Indication(s):

Generalized myasthenia gravis (gMG)

Sponsor/Manufacturer:

UCB Canada Inc.

CDA-AMC Project Number:

SR0846-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable